The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The cost of thromboembolic events in French hospitalized patients with breast or prostate cancer.
Isabelle Borget
Honoraria - LEO Pharma
Alexandre Vainchtock
Research Funding - Teva
Florian Scotte
Honoraria - LEO Pharma